Dtpa-bma

CAS : 119895-95-3

Ref. 3D-UEA89595

Informations sur le produit

• Nom: Dtpa-bma
• Synonymes: 2,5,8,11-Tetraazatridecan-13-oic acid, 5,8-bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-, 5,8-Bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-oic acid, N,N-bis(2-{(carboxymethyl)[2-(methylamino)-2-oxoethyl]amino}ethyl)glycine, DTPA-BMA

Description

Dtpa-bma is an anticancer agent that acts as a kinase inhibitor. It has been shown to induce apoptosis in cancer cells by inhibiting the activity of kinases, which are enzymes that play a key role in cell signaling pathways. Dtpa-bma is an analog of Chinese hamster ovary (CHO) cell-derived ghrelin and is excreted in urine. This drug is effective against various types of cancer, including human tumors, and has been shown to inhibit tumor growth in vivo. Dtpa-bma is formulated as a cellulose-based resin for use in chromatography purification processes.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 419.43 g/mol
• Formule: C₁₆H₂₉N₅O₈
• Degré de pureté: Min. 95%